PK ! g5 xl/worksheets/sheet1.xml
0
1234567890.5
4
567890.5
67
8
90.5
4
567890.5
67
8
90.5
67
8
90.5
PK ! ,C2 2 xl/worksheets/sheet2.xml
10111213141516171888071920212223
11
121314
15
16
17188807
192021
24252627282930
252627
2829
31253233
2532
33
11
121314
15
16
17188807
192021
252627
2829
2532
33
PK ! tT T xl/worksheets/sheet3.xml
34
353637383940
41424344
PK ! Od xl/worksheets/sheet4.xml
45
46
47
48
PK ! ߺN N xl/worksheets/sheet5.xml
4950
5152
53
54
55
56
57
PK ! a҉J J xl/workbook.xml
PK ! 5_, , xl/sharedStrings.xml
Amneal Pharmaceuticals INCFORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response:
0.5OMB APPROVALOMB Number:
3235-0104
Estimated average burden
hours per response:
0.5OMB Number:3235-0104Estimated average burdenhours per response:1. Name and Address of Reporting Person*Greene Jean Selden
(Last)
(First)
(Middle)
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD, THIRD FLOOR
(Street)
BRIDGEWATER
NJ
08807
(City)
(State)
(Zip)Greene Jean Selden(Last)(First)(Middle)C/O AMNEAL PHARMACEUTICALS, INC.400 CROSSING BOULEVARD, THIRD FLOORBRIDGEWATERNJ(City)(State)(Zip)2. Date of Event Requiring Statement
(Month/Day/Year)
05/04/20183. Issuer Name and Ticker or Trading Symbol
Amneal Pharmaceuticals, Inc.
[ AMRX ]4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X
Director
10% Owner
Officer (give title below)
Other (specify below)XDirector10% OwnerOfficer (give title below)Other (specify below)5. If Amendment, Date of Original Filed
(Month/Day/Year)6. Individual or Joint/Group Filing (Check Applicable Line)
X
Form filed by One Reporting Person
Form filed by More than One Reporting PersonForm filed by One Reporting PersonForm filed by More than One Reporting PersonTable II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)1. Title of Derivative Security (Instr.
4)2. Date Exercisable and Expiration Date
(Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)4. Conversion or Exercise Price of Derivative Security5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)6. Nature of Indirect Beneficial Ownership (Instr.
5)Date ExercisableExpiration DateTitleAmount or Number of SharesExplanation of Responses:Remarks:Exhibit 24 - Power of Attorney.No securities are beneficially owned.By: /s/ Bryan M. Reasons, Attorney-in-Fact05/09/2018** Signature of Reporting PersonDateReminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.* If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v).** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.PK ! ?' docProps/app.xml
Microsoft Excel0falseWorksheets5amneal pharmaceuticals incamneal pharmaceuticals inc-1amneal pharmaceuticals inc-2amneal pharmaceuticals inc-3amneal pharmaceuticals inc-4falsefalsefalse12.0000PK ! `:P P docProps/core.xml
2020-01-13T13:39:14Z2020-01-13T13:39:14ZPK ! Fjһ [Content_Types].xml
PK ! 1
xl/styles.xml
PK ! FTR R xl/theme/theme1.xml
PK ! IK K _rels/.rels
PK ! |\D xl/_rels/workbook.xml.rels
PK ! g5 xl/worksheets/sheet1.xmlPK ! ,C2 2 xl/worksheets/sheet2.xmlPK ! tT T $ xl/worksheets/sheet3.xmlPK ! Od # xl/worksheets/sheet4.xmlPK ! ߺN N &